By Peter Libby, MD, PhD, Robert O. Bonow, MD, MS, Douglas L. Mann, MD, Gordon F. Tomaselli, MD, Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, Scott D. Solomon, MD and Eugene Braunwald, MD, MD(Hon), ScD(Hon), FRCP
**Selected for Doody’s Core Titles® 2024 with "Essential Purchase" designation in Cardiology**Current, comprehensive, and evidence-based Braunwald’s Heart Disease remains the most trusted reference in the field and the leadi
...view more
**Selected for Doody’s Core Titles® 2024 with "Essential Purchase" designation in Cardiology**
Current, comprehensive, and evidence-based Braunwald’s Heart Disease remains the most trusted reference in the field and the leading source of reliable cardiology information for practitioners and trainees worldwide. The fully updated 12th Edition continues the tradition of excellence with dependable, state-of-the-art coverage of new drugs, new guidelines, more powerful imaging modalities, and recent developments in precision medicine that continue to change and advance the practice of cardiovascular medicine. Written and edited by global experts in the field, this award-winning text is an unparalleled multimedia reference for every aspect of this complex and fast-changing area.
**Selected for Doody’s Core Titles® 2024 with "Essential Purchase" designation in Cardiology**
Current, comprehensive, and evidence-based Braunwald’s Heart Disease remains the most trusted reference in the field and the leading source of reliable cardiology information for practitioners and trainees worldwide. The fully updated 12th Edition continues the tradition of excellence with dependable, state-of-the-art coverage of new drugs, new guidelines, more powerful imaging modalities, and recent developments in precision medicine that continue to change and advance the practice of cardiovascular medicine. Written and edited by global experts in the field, this award-winning text is an unparalleled multimedia reference for every aspect of this complex and fast-changing area.
Key Features
Offers balanced, dependable content on rapidly changing clinical science, clinical and translational research, and evidence-based medicine.
Includes 76 new contributing authors and 14 new chapters that cover Artificial intelligence in Cardiovascular Medicine; Wearables; Influenza, Pandemics, COVID-19, and Cardiovascular Disease; Tobacco and Nicotine Products in Cardiovascular Disease; Cardiac Amyloidosis; Impact of the Environment on Cardiovascular Health, and more.
Features a new introductory chapter Cardiovascular Disease: Past, Present, and Future by Eugene Braunwald, MD, offering his unique, visionary approach to the field of cardiology. Dr. Braunwald also curates the extensive, bimonthly online updates that include "Hot Off the Press" (with links to Practice Update) and "Late-Breaking Clinical Trials".
Provides cutting-edge coverage of key topics such as proteomics and metabolomics, TAVR, diabetocardiology, and cardio-oncology.
Contains 1,850 high-quality illustrations, radiographic images, algorithms, and charts, and provides access to 215 videos called out with icons in the print version.
Highlights the latest AHA, ACC, and ESC guidelines to clearly summarize diagnostic criteria and clinical implications.
Provides tightly edited, focused content for quick, dependable reference. Flexible format options include either one or two volumes in print, as well as a searchable eBook with ongoing updates.
Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
Author Information
By Peter Libby, MD, PhD, Brigham and Women’s Hospital, Harvard Medical School, USA; Robert O. Bonow, MD, MS, Northwestern University, Feinberg School of Medicine; Douglas L. Mann, MD, Washington University, School of Medicine; Gordon F. Tomaselli, MD, Executive Vice President; Chief Academic Officer; Dean Montefiore Medicine; Professor, Department of Medicine Einstein College of Medicine, Yeshiva University, Bronx, New York; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart and Vascular Center; Professor of Medicine, Harvard Medical School, Boston, Massachusetts; Scott D. Solomon, MD, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts and Eugene Braunwald, MD, MD(Hon), ScD(Hon), FRCP, Distinguished Hersey Professor of Medicine, Harvard Medical School, Founding Chairman, TIMI Study Group, Brigham and Women ’s Hospital, Boston, Massachusetts, USA
By Peter Libby, MD, PhD, Brigham and Women’s Hospital, Harvard Medical School, USA; Robert O. Bonow, MD, MS, Northwestern University, Feinberg School of Medicine; Douglas L. Mann, MD, Washington University, School of Medicine; Gordon F. Tomaselli, MD, Executive Vice President; Chief Academic Officer; Dean Montefiore Medicine; Professor, Department of Medicine Einstein College of Medicine, Yeshiva University, Bronx, New York; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart and Vascular Center; Professor of Medicine, Harvard Medical School, Boston, Massachusetts; Scott D. Solomon, MD, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts and Eugene Braunwald, MD, MD(Hon), ScD(Hon), FRCP, Distinguished Hersey Professor of Medicine, Harvard Medical School, Founding Chairman, TIMI Study Group, Brigham and Women ’s Hospital, Boston, Massachusetts, USA
Part I Foundations of Cardiovascular Medicine 1 Cardiovascular Disease: Past, Present, and Future 2 Global Burden of Cardiovascular Disease 3 Impact of the Environment on Cardiovascular Health 4 Clinical Trials in Cardiovascular Medicine 5 Clinical Decision-Making in Cardiology 6 Impact of Health Care Policy on Quality, Outcomes, and Equity in Cardiovascular Disease Part II Individualizing Approaches to Cardiovascular Disease 7 Applications of Genetics to Cardiovascular Medicine 8 Proteomics and Metabolomics in Cardiovascular Medicine 9 Principles of Drug Therapeutics, Pharmacogenomics, and Biologics 10 Biomarkers and Use in Precision Medicine 11 Artificial Intelligence in Cardiovascular Medicine 12 Wearable Devices in Cardiovascular Medicine Part III Evaluation of The Patient 13 History and Physical Examination: An Evidence-Based Approach 14 Electrocardiography 15 Exercise Physiology and Exercise Electrocardiographic Testing 16 Echocardiography 17 Chest Radiography in Cardiovascular Disease 18 Nuclear Cardiology 19 Cardiovascular Magnetic Resonance Imaging 20 Cardiac Computed Tomography 21 Coronary Angiography and Intravascular Imaging 22 Invasive Hemodynamic Diagnosis of Cardiac Disease 23 Anesthesia and Noncardiac Surgery in Patients with Heart Disease Part IV Preventive Cardiology 24 The Vascular Biology of Atherosclerosis 25 Primary Prevention of Cardiovascular Disease 26 Systemic Hypertension: Mechanisms, Diagnosis, and Treatment 27 Lipoprotein Disorders and Cardiovascular Disease 28 Cardiovascular Disease Risk of Nicotine and Tobacco Products 29 Nutrition and Cardiovascular and Metabolic Diseases 30 Obesity: Medical and Surgical Management 31 Diabetes and the Cardiovascular System 32 Exercise and Sports Cardiology 33 Comprehensive Cardiac Rehabilitation 34 Integrative Approaches to the Management of Patients with Heart Disease Part V Atherosclerotic Cardiovascular Disease 35 Approach to the Patient with Chest Pain 36 Coronary Blood Flow and Myocardial Ischemia 37 ST-Elevation Myocardial Infarction: Pathophysiology and Clinical Evolution 38 ST-Elevation Myocardial Infarction: Management 39 Non–ST Elevation Acute Coronary Syndromes 40 Stable Ischemic Heart Disease 41 Percutaneous Coronary Intervention 42 Diseases of the Aorta 43 Peripheral Artery Diseases 44 Treatment of Noncoronary Obstructive Vascular Disease 45 Prevention and Management of Ischemic Stroke Part VI Heart Failure 46 Mechanisms of Cardiac Contraction and Relaxation 47 Pathophysiology of Heart Failure 48 Approach to the Patient with Heart Failure 49 Diagnosis and Management of Acute Heart Failure 50 Management of Heart Failure Patients with Reduced Ejection Fraction 51 Heart Failure with Preserved and Mildly Reduced Ejection Fraction 52 The Dilated, Restrictive, and Infiltrative Cardiomyopathies 53 Cardiac Amyloidosis 54 Hypertrophic Cardiomyopathy 55 Myocarditis 56 Cardio-Oncology: Managing Cardiotoxic Effects of Cancer Therapies 57 Cardio-Oncology: Approach to the Patient 58 Devices for Monitoring and Managing Heart Failure 59 Mechanical Circulatory Support 60 Cardiac Transplantation Part VII Arrhythmias, Sudden Death, and Syncope 61 Approach to the Patient with Cardiac Arrhythmias 62 Mechanisms of Cardiac Arrhythmias 63 Genetics of Cardiac Arrhythmias 64 Therapy for Cardiac Arrhythmias 65 Supraventricular Tachycardias 66 Atrial Fibrillation: Clinical Features, Mechanisms, and Management 67 Ventricular Arrhythmias 68 Bradyarrhythmias and Atrioventricular Block 69 Pacemakers and Implantable Cardioverter-Defibrillators 70 Cardiac Arrest and Sudden Cardiac Death 71 Hypotension and Syncope Part VIII Diseases of the Heart Valves 72 Aortic Valve Stenosis 73 Aortic Regurgitation 74 Transcatheter Aortic Valve Replacement 75 Mitral Stenosis 76 Mitral Regurgitation 77 Tricuspid, Pulmonic, and Multivalvular Disease 78 Transcatheter Therapies for Mitral and Tricuspid Valvular Heart Disease 79 Prosthetic Heart Valves 80 Infectious Endocarditis and Infections of Indwelling Devices 81 Rheumatic Fever Part IX Diseases of the Myocardium, Pericardium, and Pulmonary Vasculature Bed 82 Congenital Heart Disease in the Adolescent and Adult 83 Catheter-Based Treatment of Congenital Heart Disease in Adults 84 Cardiomyopathies Induced by Drugs or Toxins 85 Cardiovascular Abnormalities in HIV-Infected Individuals 86 Pericardial Diseases 87 Pulmonary Embolism and Deep Vein Thrombosis 88 Pulmonary Hypertension 89 Sleep-Disordered Breathing and Cardiac Disease Part X Cardiovascular Disease in Select Populations 90 Cardiovascular Disease in Older Adults 91 Cardiovascular Disease in Women 92 Pregnancy and Heart Disease 93 Heart Disease in Racially and Ethnically Diverse Populations Part XI Cardiovascular Disease and Disorders of Other Organs 94 Endemic and Pandemic Viral Illnesses and Cardiovascular Disease: Influenza and COVID-19 95 Hemostasis, Thrombosis, Fibrinolysis, and Cardiovascular Disease 96 Endocrine Disorders and Cardiovascular Disease 97 Rheumatic Diseases and the Cardiovascular System 98 Tumors Affecting the Cardiovascular System 99 Psychiatric and Psychosocial Aspects of Cardiovascular Disease 100 Neuromuscular Disorders and Cardiovascular Disease 101 Interface Between Renal Disease and Cardiovascular Illness 102 Cardiovascular Manifestations of Autonomic Disorders
"This is the 12th edition of this leading textbook of cardiovascular medicine. The book provides a comprehensive, carefully curated, up-to-date overview of the fundamental pathophysiologic mechanisms in the field of cardiovascular disease."
"The quality and content of this book is unparalleled. This book is an invaluable resource for practicing physicians and all healthcare providers. It is a must-read book for anyone who wants to learn about cardiovascular diseases."
https://www.asia.elsevierhealth.com/braunwalds-heart-disease-2-vol-set-9780323722193.html296760Braunwald’s Heart Disease, 2 Vol Sethttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9780323722193_4.jpg221.24294.99USDInStock/Medicine & Surgery/Cardiology/Books/Medicine & Surgery/Clinical/General Medicine/Medicine/Clinical/General Medicine/Medicine/Cardiology/Books/Students/Specialty trainee/Books/Medicine/Clinical/General Medicine/Medicine/Cardiology/Japan Titles/Bestsellers/Students/Specialty trainee/Bestsellers443121243887224335102505459150545695054664505965452550395259874525985052631605263159526168750613771418269243350884886536505455350580245145120525983352598735261550<p><b>**Selected for Doody’s Core Titles® 2024 with "Essential Purchase" designation in Cardiology**</b><BR><BR>Current, comprehensive, and evidence-based <i>Braunwald’s Heart Disease</i> remains the most trusted reference in the field and the leading source of reliable cardiology information for practitioners and trainees worldwide. The fully updated 12th Edition continues the tradition of excellence with dependable, state-of-the-art coverage of <b>new drugs, new guidelines, more powerful imaging modalities, and recent developments in precision medicine</b> that continue to change and advance the practice of cardiovascular medicine. Written and edited by global experts in the field, this award-winning text is an <b>unparalleled multimedia reference</b> for every aspect of this complex and fast-changing area.</p> <p><b>**Selected for Doody’s Core Titles® 2024 with "Essential Purchase" designation in Cardiology**</b><BR><BR>Current, comprehensive, and evidence-based <i>Braunwald’s Heart Disease</i> remains the most trusted reference in the field and the leading source of reliable cardiology information for practitioners and trainees worldwide. The fully updated 12th Edition continues the tradition of excellence with dependable, state-of-the-art coverage of <b>new drugs, new guidelines, more powerful imaging modalities, and recent developments in precision medicine</b> that continue to change and advance the practice of cardiovascular medicine. Written and edited by global experts in the field, this award-winning text is an <b>unparalleled multimedia reference</b> for every aspect of this complex and fast-changing area.</p>00add-to-cart97803237221932021ProfessionalBy Peter Libby, MD, PhD, Robert O. Bonow, MD, MS, Douglas L. Mann, MD, Gordon F. Tomaselli, MD, Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, Scott D. Solomon, MD and Eugene Braunwald, MD, MD(Hon), ScD(Hon), FRCP202212Book216w x 276h (8.50" x 10.875")Elsevier2006Nov 15, 2021IN STOCKBy <STRONG>Peter Libby</STRONG>, MD, PhD, Brigham and Women’s Hospital, Harvard Medical School, USA; <STRONG>Robert O. Bonow</STRONG>, MD, MS, Northwestern University, Feinberg School of Medicine; <STRONG>Douglas L. Mann</STRONG>, MD, Washington University, School of Medicine; <STRONG>Gordon F. Tomaselli</STRONG>, MD, Executive Vice President; Chief Academic Officer; Dean Montefiore Medicine; Professor, Department of Medicine Einstein College of Medicine, Yeshiva University, Bronx, New York; <STRONG>Deepak L. Bhatt</STRONG>, MD, MPH, FACC, FAHA, FSCAI, FESC, Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart and Vascular Center; Professor of Medicine, Harvard Medical School, Boston, Massachusetts; <STRONG>Scott D. Solomon</STRONG>, MD, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts and <STRONG>Eugene Braunwald</STRONG>, MD, MD(Hon), ScD(Hon), FRCP, Distinguished Hersey Professor of Medicine, Harvard Medical School, Founding Chairman, TIMI Study Group, Brigham and Women ’s Hospital, Boston, Massachusetts, USABooksBookUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
